Credit Suisse Group Reiterates €75.00 Price Target for Fresenius Medical Care AG & Co. KGaA (FME)

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €75.00 ($87.21) price objective by equities research analysts at Credit Suisse Group in a research report issued on Wednesday. The firm presently has a “neutral” rating on the stock. Credit Suisse Group’s price target points to a potential upside of 7.20% from the stock’s current price.

Other analysts have also recently issued research reports about the stock. Sanford C. Bernstein set a €107.00 ($124.42) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, July 12th. Berenberg Bank set a €100.80 ($117.21) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, July 12th. Bank of America set a €102.00 ($118.60) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Tuesday, July 10th. Nord/LB set a €102.00 ($118.60) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Friday, July 6th. Finally, Deutsche Bank set a €105.00 ($122.09) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Monday, July 16th. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA has a consensus rating of “Buy” and an average target price of €91.86 ($106.81).

FME stock traded up €0.76 ($0.88) during trading hours on Wednesday, reaching €69.96 ($81.35). The stock had a trading volume of 547,439 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($87.83) and a fifty-two week high of €93.82 ($109.09).



Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

See Also: Investing strategies using the yield curve

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply